WHO Collaborating Centre for Metabolic Bone Diseases, University of Sheffield Medical School, Beech Hill Road, Sheffield S10 2RX, UK.
Osteoporos Int. 2012 Feb;23(2):423-31. doi: 10.1007/s00198-011-1846-0. Epub 2011 Nov 26.
Recent studies have evaluated the performance of FRAX® in independent cohorts. The interpretation of most is problematic for reasons summarised in this perspective.
FRAX is an extensively validated assessment tool for the prediction of fracture in men and women. The aim of this study was to review the methods used since the launch of FRAX to further evaluate this instrument.
This covers a critical review of studies investigating the calibration of FRAX or assessing its performance characteristics in external cohorts.
Most studies used inappropriate methodologies to compare the performance characteristics of FRAX with other models. These included discordant parameters of risk (comparing incidence with probabilities), comparison with internally derived predictors and inappropriate use and interpretation of receiver operating characteristic curves. These deficits markedly impair interpretation of these studies.
Cohort studies that have evaluated the performance of FRAX need to be interpreted with caution and preferably re-evaluated.
最近的研究评估了 FRAX®在独立队列中的表现。由于本文所述的原因,大多数研究的解释存在问题。
FRAX 是一种经过广泛验证的评估工具,用于预测男性和女性的骨折风险。本研究旨在回顾自 FRAX 推出以来使用的方法,以进一步评估该工具。
这包括对研究 FRAX 校准或评估其在外部队列中的性能特征的方法进行批判性回顾。
大多数研究使用不适当的方法来比较 FRAX 的性能特征与其他模型。这些方法包括风险参数不一致(比较发病率与概率)、与内部衍生预测因子的比较以及对接收者操作特征曲线的不适当使用和解释。这些缺陷严重影响了对这些研究的解释。
评估 FRAX 性能的队列研究需要谨慎解释,最好重新评估。